Cargando…
The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update
As a standard treatment, endocrine therapy has dramatically enhanced the prognosis of patients with estrogen receptor (ER)-positive breast cancer, which accounts for nearly 70% of all breast cancers. Antiestrogen drugs such as tamoxifen and aromatase inhibitors are the standard treatment options for...
Autores principales: | Huang, Lan, Liang, Guohua, Zhang, Qingyuan, Zhao, Wenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192751/ https://www.ncbi.nlm.nih.gov/pubmed/32395373 http://dx.doi.org/10.4048/jbc.2020.23.e10 |
Ejemplares similares
-
The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
por: Suba, Zsuzsanna
Publicado: (2015) -
Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data
por: Zhang, Denan, et al.
Publicado: (2014) -
An Update of Long-Noncoding RNAs in Acute Kidney Injury
por: Yang, Lina, et al.
Publicado: (2022) -
Update on the role of noncoding RNAs in vitiligo
por: Zhou, Ting, et al.
Publicado: (2022) -
Long Noncoding RNAs in Taxane Resistance of Breast Cancer
por: Chen, Hailong, et al.
Publicado: (2023)